Delivery Order SPE2DB24D2010-SPE2DB24FZTW0
- Not listed
- This federal contract award is for the delivery of Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,275.62 and is a delivery order with a firm fixed price pricing type. The period of performance runs through April 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,742.98 and an ultimate completion date of May 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 2.5 mg/0.5 ml pen with a total ceiling value of $1,052.00. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of 4,560,259,125 units of the drug Mounjaro 2.5 mg/0.5 ml pen. The contract, valued at $1,578.00, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract type is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 15, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award is for the delivery of the drug Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,574.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 18, 2023. This contract does not have a set-aside designation, indicating it...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro (15 mg/0.5 ml pen) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,365.78 and a completion date of May 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pens, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,027.68 and an ultimate completion date of April 29, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The award, valued at $1,052.00, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of December 14, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- The federal contract award is for the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $3,991.12 and an ultimate completion date of October 28, 2024. The contract was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. AmerisourceBergen Drug Corp...
- This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,630.00 and an ultimate completion date of April 16, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZTW0Delivery Order
This federal contract award is for the delivery of the pharmaceutical product Mounjaro 2.5 mg/0.5 mL pen in 0.5 mL dosage. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,058.83 and a period of performance through April 26, 2024. This award is not set aside for any specific business classification. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly to support military and veterans' healthcare programs. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 4/25/24 |